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Abstract
Background: Rhabdomyosarcoma is a relatively common tumour of the soft tissue, probably due
to regulatory disruption of growth and differentiation of skeletal muscle stem cells. Identification
of genes differentially expressed in normal skeletal muscle and in rhabdomyosarcoma may help in
understanding mechanisms of tumour development, in discovering diagnostic and prognostic
markers and in identifying novel targets for drug therapy.
Results: A Perl-code web client was developed to automatically obtain genome map positions of
large sets of genes. The software, based on automatic search on Human Genome Browser by
sequence alignment, only requires availability of a single transcribed sequence for each gene. In this
way, we obtained tissue-specific chromosomal maps of genes expressed in rhabdomyosarcoma or
skeletal muscle. Subsequently, Perl software was developed to calculate gene density along
chromosomes, by using a sliding window. Thirty-three chromosomal regions harbouring genes
mostly expressed in rhabdomyosarcoma were identified. Similarly, 48 chromosomal regions were
detected including genes possibly related to function of differentiated skeletal muscle, but silenced
in rhabdomyosarcoma.
Conclusion: In this study we developed a method and the associated software for the comparative
analysis of genomic expression in tissues and we identified chromosomal segments showing
differential gene expression in human skeletal muscle and in alveolar rhabdomyosarcoma, appearing
as candidate regions for harbouring genes involved in origin of alveolar rhabdomyosarcoma
representing possible targets for drug treatment and/or development of tumor markers.
Background
Rhabdomyosarcoma (RMS) is the most common sarcoma
of the soft-tissue, the third most common extracranic
solid tumor in children [1]. The incidence of RMS is about
four new cases per million per year [2]. RMS is believed to
arise from regulatory disruption of growth and differenti-
ation of skeletal muscle stem cells [3,4].
Several approaches, such as FISH, Comparative Genomic
Hybridization (CGH), representational difference analy-
sis [5-7] were proposed to investigate at a genomic level
DNA amplification in tumour samples. Microarray tech-
nology methods, applied to identification of genome-
wide chromosomal imbalances tried to overcome limita-
tions of conventional CGH by hybridizing sample DNA to
mapped sequences instead of metaphase chromosomes
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[8]. More recently, comparative expressed sequence
hybridisation (CESH) was applied to the analysis of chro-
mosomal regions including genes overexpressed in a
leukemic cell line and in four rhabdomyosarcoma cell
lines [9]. A number of discrete regions of increased
tumour expression (RITEs) have been identified by a com-
putational method, which compared gene expression lev-
els in unbiased EST libraries from tumour and normal
tissues. Several RITEs were identified, corresponding to
chromosomal segments previously detected by CGH anal-
ysis. Permutation analyses suggested that chromosomal
and genomic distribution of RITEs is probably not ran-
dom [10]. Unfortunately, this study did not consider mus-
cle tissues or muscle tumours.
The aim of this study was to build and compare transcript
maps of normal human skeletal muscle and of alveolar
rhabdomyosarcoma, in order to identify specific regions
of the human genome involved in development of this
tumour. This would facilitate discovery of novel genes
playing a role in rhabdomyosarcoma and, possibly, of
novel tumour markers.
In this paper we report on detection of chromosomal
regions harbouring genes mostly expressed in RMS or
downregulated in RMS, if compared with normal skeletal
muscle, by using different computational methods.
Results and Discussion
Reconstruction of expression profiles at genome level
We reconstructed tissue expression profiles by a computa-
tional approach, starting from unbiased cDNA libraries
data. In particular, the expression profile of normal adult
skeletal muscle (SM) was reconstructed by using informa-
tion from 26,964 ESTs, corresponding to 8,517 genes
expressed in SM, such as from data obtained by merging
four cDNA libraries. Human alveolar rhabdomyosarcoma
(ARMS) expression profile was reconstructed from 24,175
ESTs, derived from one library, accounting for 4,549 genes
expressed in ARMS. Full data are accessible online [11].
The number of ESTs reported in each UniGene cluster
recorded in the expression profile was used to estimate the
level of activity of the corresponding gene, as previously
described [12], under the assumption that the number of
detected ESTs per gene is a function of its transcript fre-
quency in the original population of messenger RNA.
Thus, each expression profile is a catalogue of genes
expressed in a given tissue. Each gene in the catalogue is
identified by UniGene cluster ID and RefSeq accession
number and it is associated to the encoded product
description and linked to LocusLink and to GenBank
databases.
Estimation of density of expressed genes along 
chromosomes
Genomic map positions, established at one-nucleotide
level of resolution, were obtained by querying UCSC
BLAT facility with representative DNA sequences of each
of 8,517 genes expressed in skeletal muscle and of 5,520
genes expressed in ARMS, according to RefSeq or to Uni-
Gene database. Location of each gene in the human
genome sequence is given by starting and ending position
of the transcribed region, expressed as bp distances from
the short arm telomere.
After stringent alignment quality check (see Methods)
98% of genes considered by the study were unambigu-
ously located to their chromosomal positions. In particu-
lar, the precise chromosomal location was determined for
8,308 genes expressed in SM and for 5,414 genes
expressed in ARMS.
Chromosomal base-pair coordinates of such genes were
used to establish "gene density" along each chromosome.
Gene density was expressed as a fraction of the genomic
sequence covered by gene-associated sequences, in chro-
mosomal regions spanned by a sliding window. Gene
density of skeletal muscle genes and of ARMS genes was
calculated using 1 Mb-wide windows with 10 Kb overlap,
thus obtaining 304,691 different values of gene density
along the whole human genome. Window width was set
to 1 Mb, in order to scan the genome with a window wider
than the average length of most human genes. Taking into
account that the average size of human genes is about 14
Kb and the median value is 27 Kb [13], that gene density
is highly variable in the human genome, ranging from
zero to about 100 genes per Mb (e.g. 6p21.33), and that
only a fraction of all human genes is expressed in a given
tissue, the selected dimension of one megabase for the
window used in the present study should be adequate for
measuring gene density in the human genome. The shift
between adjacent windows was set to 10 Kb, in order to
obtain sufficiently numerous data points, for a precise cal-
culation of gene density along human chromosomes.
Comparison between density of genes expressed in normal 
skeletal muscle and ARMS
Gene density values, normalized to the total number of
expressed genes, were plotted against the base-pair scale
length of different human autosomes and of the X
chromosome.
Observed gene density values ranged from zero to 1.993
for SM and from zero to 1.197 for ARMS. Average gene
density were 0.129 and 0.069 for SM and ARMS, respec-
tively. The difference between normalised ARMS and nor-
mal skeletal muscle gene densities was measured. For
27.6% of the genome ARMS gene density was higher thanBMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/68
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Table 1: Muscle and RMS gene density in the human genome.
Chr. Chromosomal regions Diff. expr. 
in RMS
Chr. Chromosomal regions Diff. expr. 
in RMS
Start(Mb) End(Mb) Cyt. band Start(Mb) End(Mb) Cyt. band
1 14.09 14.75 p36.21* +
50.16 50.79 p32.3 +
63.86 64.11 p31.3 + 13 59.57 59.69 q21.2 +
91.99 92.09 p22.1 - 94.91 95.14 q32.1 -
96.84 97.50 p21.3 -
173.14 173.59 q25.2 -
2 29.21 30.22 p23.2 – p23.1* +
50.05 51.22 p16.3 -
79.57 81.03 p12 -
99.66 100.17 q11.2 - 14 65.07 65.58 q23.3 -
137.73 138.53 q22.1 + 71.51 71.57 q24.2 -
143.91 144.65 q22.2-q22.3 +
205.48 206.28 q33.3 -
212.32 213.26 q34 -
3 2.03 3.16 p26.3-p26.2 +
29.28 29.78 p24.1 -
37.17 37.19 p22.3 -
37.24 37.61 p22.3 -
53.92 55.06 p21.1-p14.3* +
61.51 62.03 p14.2 - 15 22.97 23.04 q11.2 -
76.79 77.61 p12.3* +
101.86 102.32 q12.2-q12.3 -
116.71 117.55 q13.31 +
160.38 160.91 q25.33 -
176.08 176.82 q26.31 -
4 53.52 54.15 q12 +
87.50 88.06 q21.3 -
114.54 114.90 q25-q26 - 16 82.50 83.51 q23.3 -
151.75 152.30 q31.23-q31.3 - 88.74 88.88 q24.3* +
162.88 163.45 q32.2 -
168.14 168.84 q32.3 +
5 19.37 20.08 p14.3 +
89.80 90.59 q14.3 + 17 44.45 44.72 q21.31 -
92.87 93.54 q15 + 45.08 45.13 q21.31 -
168.12 168.58 q34-q35.1 -
6 1.51 2.39 p25.3-p25.2 +
20.70 21.19 p22.3 -
37.94 38.43 p21.2 -
44.67 45.37 p21.1* + 18 7.66 8.29 p11.23 -
69.40 70.07 q12-q13 - 49.86 50.84 q21.1-q21.2 -
128.69 129.74 q22.33 -
152.69 153.01 q25.2 +
7 36.54 37.32 p14.2-p14.1 +
68.36 69.76 q11.22* +
100.90 10.1 q22.1* + 19 38.48 38.54 q13.11* +
109.95 110.64 q31.1 -
132.56 133.21 q33 -
8 98.97 99.41 q22.2 - 20 8.18 8.71 p12.3 -BMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/68
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SM. The absolute value of gene density difference was
higher than 0.3 for 10,653 windows (7.6%). A total of
2,384 windows showing over 0.6 absolute difference were
observed (0.7%), corresponding to 33 chromosomal
regions harbouring genes overexpressed in ARMS if com-
pared with SM and to 48 chromosomal segments, which
appeared strongly downregulated in ARMS (Table 1 and
Figure 2). The 0.6 threshold for the observed difference of
gene density has been selected in order to pick up
genomic regions in which the difference was either mod-
erate or high, without producing an unmanageable
increase of genomic regions included and, in particular, to
avoid their fragmentation.
Complete plots of gene densities along different human
chromosomes are available as supplementary material at
our website [14]. As an example, details of the human X
chromosome are shown in Figure 1.
Identification of genes differentially expressed in normal
and tumour tissues may provide a valuable help in under-
standing tumour development, in discovering diagnostic
and prognostic markers and in identifying novel targets
for drug therapy. Digital expression profiling of six differ-
ent solid tumour types has been used for discovering
novel cancer genes [15], but the data set included both
normalized and subtracted cDNA libraries and Fisher's
exact test was inappropriately used. Artificial neural net-
works have been used to classify different cancer samples
or cell lines on the basis of their expression signature [16].
As far as ARMS is concerned, a cDNA microarray study
showed consistent patterns of gene expression in different
ARMS cell lines [17].
In the present study, by associating transcripts to the cor-
responding gene sequence on the human genome, we
mapped at genomic level genes expressed in SM and in
ARMS. Moreover, we calculated density along each
human chromosome of such genes, by using a sliding
window approach. Because of the relatively low gene den-
sity per window, a statistical approach for comparing gene
density was considered to be less convenient than a "qual-
itative", plot-based approach.
In human genome, possible clustering of genes highly or
specifically expressed in specific tissues has been
suggested by different studies (see for instance [18-20])
which considered both normal and cancer tissues. Fujii
and colleagues [21] found that numerous groups of genes
expressed in specific tumours, such as squamous cell car-
cinoma or adenocarcinoma, cluster in given regions of the
human genome. On the other hand, recurrent non ran-
dom imbalances pertaining specific chromosomal regions
are frequently reported in tumours. Several experimental
or computational methods are currently used for identifi-
cation of such regions.
We identified specific chromosomal regions hosting more
genes expressed in ARMS than expressed in SM. This pro-
vides a starting point for identifying novel candidate can-
9 8.41 8.90 p24.1 -
109.93 109.99 q32* + 21 16.32 16.61 q21.1 -
112.29 113.53 q32-q33.1* +
121.63 122.47 q33.3* +
10 0.50 0.75 p15.3* +
52.83 53.84 q21.1 -
75.66 76.54 q22.2* + 22 31.87 32.74 q12.3* +
78.64 79.18 q22.3 -
94.41 94.48 q23.33 -
108.33 109.16 q25.1 +
11 10.20 10.28 p15.4 -
10.34 10.34 p15.4 - X 8.74 9.47 p22.31-p22.22* +
20.60 21.90 q22.3 + 83.54 84.02 q21.2 -
83.50 84.83 q14.1 - 94.08 94.79 q21.33 -
12 26.85 26.92 p11.23 - Y -- -
Local density of genes expressed in skeletal muscle and in RMS was calculated on the basis of 304,691 sliding windows, 1 Mb-wide and with 10 Kb 
overlap. Chromosomal regions in which the absolute difference between RMS and skeletal muscle gene density was over 0.6 were selected. Thirty-
three chromosomal regions harbouring mostly genes expressed in RMS and 48 chromosomal segments, possibly related to function of 
differentiated skeletal muscle but silent in RMS are reported. Regions including chromosomal segments in which absolute difference between ARMS 
and skeletal muscle gene density exceeded 1.0 are in bold, whereas asterisks indicate regions in which overexpression of tumour genes has been 
reported for different tissues by Zhou and colleagues [10].
Table 1: Muscle and RMS gene density in the human genome. (Continued)BMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/68
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cer genes. On the other hand, comparison of
chromosomal maps of genes expressed respectively in SM
or in ARMS revealed the existence of genome regions pos-
sibly involved in muscle differentiation. Further analysis
of these regions could help in understanding why ARMS
cells fail to differentiate.
In regions harboring more genes expressed in ARMS than
in normal muscle a number of novel genes are present,
such as genes with uncharacterized products, hypothetical
proteins or transcribed sequences. Among known genes,
some are particularly interesting, such as genes encoding
for transcription factors or for proteins involved in cell
cycle control, in signal transduction or in cell adhesion.
For some of them, an involvement in tumors has been
already reported. Nine genes encoding transcriptional fac-
tors and/or regulators of cell cycle lie in chromosomal
regions harboring mostly genes expressed in RMS (DMRT-
like family A2, 1p32.3; Transcription factor SMIF, 3p21.1-
p14.3; Zinc finger protein 288, 3q13.31; Suppressor of Ty
3 homolog, 6p21.1; Zinc finger, HIT domain containing
1, 7q22.1; Tripartite motif-containing 32, 9q32.-q33.1;
Pre-B-cell leukemia transcription factor 3, 9q33.3;
PPP3CB: Protein phosphatase 3, catalytic subunit, beta
isoform, 10q22.2; Adenovirus 5 E1A binding protein,
10p15.3 and NEL-like 1, 11q22.3). Four genes encoding
for adhesion molecules, are also located in regions
overexpressed in RMS (Contactin 4; Cadherin 18, Mono-
genic, audiogenic seizure susceptibility 1 homolog and
Vinculin, found in 3p26.3-p26.2; 5p14.3, 5q14.3 and
10q22.2, respectively). Moreover, two oncogenes (Ana-
plastic lymphoma kinase and Nucleophosmin) map in
2p23.2-p23.1, whereas the "upregulated in colorectal can-
cer gene 1" maps in 7p14.2-p14.1 and the gene for the
inhibitor of metalloproteinase 3, whose expression is
induced in response to mitogenic stimulation, maps in
22q12.3.
An effort was made to compare our results with CESH
data [9], but the two approaches are different in terms of
Density of skeletal muscle and of RMS genes associated sequences along human X chromosome Figure 1
Density of skeletal muscle and of RMS genes associated sequences along human X chromosome. Gene density 
was calculated in chromosomal regions spanned by sliding windows, as the fraction of genomic sequence covered by gene-
associated sequences, on the basis of 15,165 windows of 1 Mb with an overlap between adjacent windows of 10 Kb. As an 
example, details about gene density on the human X chromosome are shown. Gene density values were normalized to the 
total number of expressed genes and plotted together on the same base-pair scale axis. Chromosomal regions in which abso-
lute difference between RMS and skeletal muscle gene density was over 0.6 were selected. On the X chromosome, one region 
resulted to harbour mostly genes expressed in RMS (p22.31-p22.22) and two regions resulted to contain genes expressed in 
fully differentiated muscle but silent in RMS (q21.2 and q21.33). Complete plots of gene densities along all human chromo-
somes are available as supplementary material [14].
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sensitivity. At its highest definition CESH measures
hybridization intensities on a 450-bands resolution met-
aphase, whereas our procedure localizes genes on the
human genome sequence, at single nucleotide level.
However, it may be noticed that in the present study we
identified with high confidence one chromosomal region
(2p23.2-p23.1) containing a segment showing considera-
ble differential gene density between RMS and SM, within
a chromosomal region in which overexpression of RMS
Regions of human chromosomes with absolute difference between RMS and skeletal muscle gene density over 0.6 Figure 2
Regions of human chromosomes with absolute difference between RMS and skeletal muscle gene density over 
0.6. Thirty-three chromosomal regions harboring mostly genes expressed in RMS are boxed with continue line, whereas 48 
chromosomal segments, possibly related to function of differentiated skeletal muscle but silent in RMS are indicated by dashed 
boxes.
q32.2
q25-q26
q21.3
q12
q31.23-q31.3
q34-q35.1
q15
q14.3
p14.3
p25.3-p25.2
p22.3
q25.2
q22.33
q12-q13
p21.1
p21.2
q11.22
q33
q31.1
q22.1
p14.2-p14.1
q22.3
q32-q33.1
q33.3
p24.1
q23.33
q25.1
q22.3
q22.2
q21.1
p15.3
q22.3
q14.1
p15.4
p11.23
q32.1
q21.2
q24.2
q23.3
q24.3
q23.3
q21.31 q21.1-q21.2
p11.23
q13.11
p12.3
q21.1 q12.3
q21.33
q21.2
p22.31-p22.22
p36.21
p32.3
p31.3
p22.1
p21.3
q25.2
p23.2-p23.1
p16.3
p12
q11.2
q22.1
q22.2-q22.3
q33.3
q34
p26,3-p26.2
q13.31
q12.2-q12.3
q26.31
q25.33
p12.3
p14.2
p22.3
p24.1
q11.2
p21.1-p14.3
1 2 3 4 5 6
7 8 9 10 11 12
18 17 16 15 14 13
19 20 21 22 X YBMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/68
Page 7 of 9
(page number not for citation purposes)
genes was detected by CESH [9]. In addition, in the long
arm of chromosome 6, reportedly underexpressed in all
ARMS lines analyzed by CESH, we found four different
regions harboring genes expressed in SM but silenced in
ARMS.
From a technical point of view, comparison with the work
reporting detection of RITEs [10] was more feasible and
meaningful even if they did not take in consideration any
SM or ARMS library. We compared chromosomal regions
harboring genes more expressed in ARMS than in SM with
the list of regions showing increased gene expression in
tumour of brain, breast, liver, and lung, identified by
Zhou and colleagues [10]. We found that many regions
showing higher gene densities in ARMS than in SM were
included in this list of regions of increased expression in
tumours of several tissues (these regions are indicated
with asterisks in Table 1). Therefore, some of these regions
could be associated to a general neoplastic phenotype,
consequent to genomic rearrangements or due to deregu-
lation of expression of adjacent genes.
Chromosomal regions where differential expression of
genes was noticed in ARMS in this study, but were never
reported previously, appear as candidate regions for har-
boring genes possibly involved in origin of ARMS or pos-
sible targets for chemotherapy.
Several recurring cytogenetical abnormalities have been
observed by Comparative Genomic Hybridization (CGH)
studies in RMS cell lines. They involved the gain or loss of
complete chromosomes or of specific chromosomal
regions. In spite of the different nature of these data, we
attempted to find possible overlap between the location
of chromosomal segments apparently rich or poor in
genes expressed in RMS, identified by the present study,
with those of chromosomal regions reportedly involved
in prominent imbalances observed in rhabdomyosar-
coma by several CGH studies. Several correspondences
between ESTs based and CGH results were observed, such
as overexpression of RMS genes in chromosomal regions
reportedly amplified or translocated in RMS, and under-
expression of RMS genes in genomic regions deleted in
RMS. In particular, overexpression of genes in ARMS, in
regions 1p31.3, 3p12.3, 22q12.3 and 7p14.2-14.1, is con-
sistent respectively with 1p31-p21, 3p12 and 22q ampli-
fication and gain of 7p reported by Gordon and
colleagues [22]. Underexpression of ARMS genes in
regions, 3p24.1, 3p22.3, 3p14.2, 5q34-q32.1, 10q23.33
and 13q32.1 is consistent with loss of 3p, 5q32-qter,
10q23 and chromosome 13 [22]. Furthermore, gain of 2q,
reported in 40% of 45 different samples of alveolar and
embryonal RMS, 7q (31%), 11q (31%) and 16q (27%)
[23] is consistent with our finding of overexpression in
RMS of regions 2q22.1 and 2q22.2-q22.3, 7q11.22 and
7q22.1, 11q22.3 and 16q23.3. Moreover, Pandita and
colleagues [24] reported gain of regions of chromosomes
2, 5, 7, 8, 11 and 12 in the majority of considered RMS,
which is consistent with our findings of eleven distinct
regions in these chromosomes harbouring genes
expressed in ARMS but silent in SM.
Conclusions
In this study we developed a method and the associated
software for the comparative analysis of gene expression
in genome. All developed software is freely available
online [14]. We identified chromosomal segments show-
ing differential gene expression in human skeletal muscle
and in alveolar rhabdomyosarcoma, which appear as can-
didate regions for harboring genes involved in origin of
ARMS and for being possible targets for drug treatment or
markers of tumour development.
Methods
We considered for the study only "unbiased" UniGene
cDNA libraries pertaining to selected human tissues, such
as cDNA clones collections which did not underwent, dur-
ing their construction, normalization or subtraction proc-
esses. These methods deeply bias ESTs frequencies and
alter correlation between frequency of ESTs pertaining to
a specific gene in the library and gene expression level in
the considered tissue.
The expression profile of normal adult skeletal muscle
(SM) was reconstructed by pooling four cDNA libraries
(LibIDs: 45, 530, 6761, 9692). Human alveolar rhab-
domyosarcoma (ARMS) expression profile was recon-
structed from one very large cDNA library (LibID: 3714).
All data presented in this paper were mined from Uni-
Gene release #159 [25], by perl software designed for
completing a fully automated procedure for data retrieval
and expression profiles reconstruction. After download-
ing human UniGene clusters and libraries data, expres-
sion profiles are reconstructed by eventual pooling of
libraries and calculation of expression data. HTML pages
are automatically built. Each gene in a profile is identified
by gene name and description, UniGene cluster,
LocusLink number and GenBank ID of the longest
sequence representative of the cluster.
The number of ESTs per each UniGene cluster, pertaining
to a specific gene in a given library (or pool of libraries),
was used to estimate the gene expression level as a per-
centage of the total detected transcriptional activity in the
tissue (total number of ESTs per library or pool of librar-
ies)[11]. The whole computational work was accom-
plished by a software pipeline estimating the level of
expression of genes and producing expression profiles,
integrating gene expression and annotation data in HTMLBMC Bioinformatics 2004, 5 http://www.biomedcentral.com/1471-2105/5/68
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format with links to external resources as LocusLink and
GenBank databases. The interactive console tool is con-
ceived to give the possibility of automatically download
of large UniGene files and of lists of cDNA libraries files.
By simple commands expression profiles are produced.
Different profiles could also be merged to create expres-
sion data matrices.
A perl-code web client was developed to automatically
obtain genome map positions of large sets of genes,
requiring only the availablility of a transcribed sequence
for each gene. Gene location was established at a nucle-
otide level resolution, by iteratively querying BLAT search
facility at UCSC [26] with the representative nucleotide
sequence. Representative sequences of UniGene clusters,
or, whenever available, reference sequences of corre-
sponding genes, as established by NCBI RefSeq project
[27], were used. BLAT, after searching for similarity
between the query sequence and the human genome
assembly, outputs the best scoring alignments. We
defined stringent thresholds for extension and identity of
alignments reported between genomic and query nucle-
otide sequences, in order to exclude spurious results: only
alignments extending for more than 400 bp with an iden-
tity percentage greater than 95% were considered. In this
way, we obtained tissue-specific chromosomal maps of
genes expressed in rhabdomyosarcoma or muscle, encom-
passing the whole genome. The web client takes as input
file a list of UniGene clusters and needs the Hs.data and
Hs.sequniq files and their indexes. For each gene, gene
name and sequence could be retrieved and this informa-
tion is used to BLAT the sequence to the Human Genome
Sequences and to produce a file output with the list of
UniGene clusters genomic positions.
Perl software was also developed to calculate gene density
along chromosomes, by using a sliding window. Basically,
using as input a list of chromosome lengths in bp and a
list of gene locations (start and end of transcribed regions,
as bp distances from the p telomere) and given selected
window size and length of overlap between adjacent win-
dows, the software allow the calculation of gene density
along chromosomes with the method of sliding windows.
The calculated gene density for a specific window is asso-
ciated to its central point and, ultimately, a list of gene
densities is compiled.
For each of reconstructed expression profiles, a list of
sequences, corresponding to the set of detected tran-
scripts, and the base-pair coordinates corresponding to
their start and ending points on the human genome
assembly, were used to calculate, for each profile, the frac-
tion of the genome covered by gene associated sequences.
A density value, calculated on the selected window length,
was therefore associated to the point coordinate of the
human genome sequence corresponding to the center of
that window. In this study, gene densities were calculated
by using a window length of 1 Mb and a shift of 10 Kb. In
presence of overlapping genes, the contribution of each
one to the coverage was considered separately. Therefore,
the calculated "gene density" resulted to be more than one
in some regions.
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